BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
57,62 $ ↑1,19 (2,11%)
2026-06-05
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership16,309 shares
Latest Disclosed Value $ 921,295
ProShare Advisors LLC reports 0.82% increase in ownership of 0HNC / BioMarin Pharmaceutical Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 16,309 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $908,411 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 16,177 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 0.82% during the quarter. The current value of the position is $939,725 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,309 132 0.82 921 -4.16 0.0014
2026-02-06 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,177 1,170 7.80 961 18.35 0.0017
2025-11-06 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,007 -659 -4.21 813 -5.69 0.0017
2025-08-07 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,666 -1,060 -6.34 861 -27.16 0.0017
2025-05-08 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,726 -1,218 -6.79 1,182 0.25 0.0027
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,944 -1,605 -8.21 1,179 -14.19 0.0027
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,549 -1,128 -5.46 1,374 -19.27 0.0034
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,677 7,456 56.40 1,702 47.49 0.0046
2024-05-08 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,221 1,185 9.85 1,155 -0.52 0.0031
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,036 -266 -2.16 1,161 6.62 0.0035
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,302 157 1.29 1,088 3.42 0.0034
2023-08-10 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,145 -787 -6.09 1,053 -16.31 0.0031
2023-05-26 2023-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 12,932 -5,258 -28.91 1,258 -33.21 0.0038
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,932 -5,258 1,258 0.0040
2023-02-02 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,190 -366 -1.97 1,882 19.64 0.0066
2022-11-07 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,556 1,119 6.42 1,573 8.86 0.0060
2022-08-01 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,437 -5,807 -24.98 1,445 -19.36 0.0048
2022-05-10 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 23,244 -7,226 -23.72 1,792 -33.43 0.0038
2022-02-08 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,470 -13,044 -29.98 2,692 -19.95 0.0053
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 43,514 4,065 10.30 3,363 2.16 0.0094
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,449 10,866 38.02 3,292 52.55 0.0096
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,583 -2,700 -8.63 2,158 -21.33 0.0068
2021-02-09 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,283 -127,661 -80.32 2,743 -77.32 0.0102
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 158,944 23,073 16.98 12,092 -27.84 0.0559
2020-08-03 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 135,871 19,113 16.37 16,758 69.86 0.0895
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 116,758 -45,177 -27.90 9,866 -27.94 0.0709
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 161,935 3,786 2.39 13,692 28.45 0.0634
2019-11-12 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 158,149 1,089 0.69 10,659 -20.76 0.0597
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 157,060 -19,852 -11.22 13,452 -14.40 0.0804
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 176,912 2,142 1.23 15,715 5.60 0.0940
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 174,770 17,544 11.16 14,882 -2.39 0.1042
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 157,226 -7,827 -4.74 15,246 -1.94 0.1035
2018-08-13 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 165,053 -17,577 -9.62 15,548 5.01 0.1042
2018-05-14 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 182,630 7,010 3.99 14,806 -5.45 0.0965
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 175,620 16,812 10.59 15,660 5.95 0.1086
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 158,808 15,735 11.00 14,780 13.74 0.1358
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 143,073 7,373 5.43 12,994 9.08 0.1294
2017-05-12 2017-03-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 135,700 -20,898 -13.34 11,912 -8.18 0.1246
2017-05-08 2017-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 135,700 0 11,912 0.1246
2017-04-25 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 135,700 11,912
2017-02-13 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 156,598 14,823 10.46 12,973 -1.10 0.1437
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 141,775 -31,106 -17.99 13,117 -2.48 0.1832
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 172,881 1,486 0.87 13,450 -4.86 0.1733
2016-05-06 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 171,395 -17,845 -9.43 14,137 -28.69 0.1946
2016-02-05 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 189,240 7,719 4.25 19,825 3.70 0.2401
2015-11-06 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 181,521 44,670 32.64 19,118 2.14 0.2685
2015-08-11 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 136,851 652 0.48 18,718 10.28 0.2590
2015-05-08 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 136,199 136,199 0.00 16,973 0.1999
2015-01-30 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -81,347 -100.00 0 -100.00
2014-11-06 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 81,347 -13,730 -14.44 5,870 -0.76 0.0778
2014-08-08 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 95,077 -20,689 -17.87 5,915 -25.09 0.0766
2014-05-07 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115,766 48,509 72.12 7,896 67.08 0.0987
2014-02-04 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 67,257 13,951 26.17 4,726 22.75 0.0704
2013-11-07 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 53,306 22,985 75.81 3,850 127.54 0.0914
2013-07-25 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,321 30,321 1,692 0.0332
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.